Tan Jennifer, Surti Bijal, Saab Sammy
Department of Medicine, David Geffen School of Medicine, University of California-Los Angeles, Los Angeles, CA 90095, USA.
Liver Transpl. 2008 Aug;14(8):1081-91. doi: 10.1002/lt.21572.
As the treatment of cirrhosis improves, pregnancy in patients with cirrhosis is likely to become more common. Although maternal and fetal mortality is expected to similarly improve, pregnant patients with cirrhosis face unique risks. These include higher rates of spontaneous abortion and prematurity and a potential for life-threatening variceal hemorrhage, hepatic decompensation, splenic artery aneurysm rupture, and postpartum hemorrhage. Pregnancy outcome may be influenced by the underlying etiology of liver disease, as in viral and autoimmune hepatitis. Medications also impact the course of pregnancy, and must be tailored appropriately during this time.
随着肝硬化治疗方法的改进,肝硬化患者怀孕的情况可能会变得更加普遍。尽管预计母婴死亡率也会同样降低,但肝硬化孕妇面临着独特的风险。这些风险包括自然流产和早产的发生率较高,以及存在危及生命的静脉曲张破裂出血、肝失代偿、脾动脉瘤破裂和产后出血的可能性。妊娠结局可能会受到肝病潜在病因的影响,如病毒性肝炎和自身免疫性肝炎。药物也会影响妊娠过程,在此期间必须进行适当调整。